- FoI Number
- 2024-583
- Subject
- Biologics
- Date Received
- 03/01/2025
- Request and Response
-
Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland does not have a Rheumatology Department.
• Abatacept [Orencia]
• Adalimumab [Humira]
• Adalimumab Biosimilars
• Apremilast [Otezla]
• Baricitinib [Olumiant]
• Bimekizumab [Bimzelx]
• Certolizumab [Cimzia]
• Etanercept [Enbrel]
• Etanercept Biosimilars
• Filgotinib [Jyseleca]
• Golimumab [Simponi]
• Guselkumab [Tremfya]
• Infliximab [Remicade]
• Infliximab Biosimilars
• Ixekizumab [Taltz]
• Risankizumab [Skyrizi]
• Rituximab [MabThera]
• Rituximab Biosimilars
• Sarilumab [Kevzara]
• Secukinumab [Cosentyx]
• Tocilizumab [Ro Actemra]
• Tocilizumab Biosimilars
• Tofacitinib [Xeljanz]
• Upadacitinib [Rinvoq]
• Ustekinumab [Stelara]
• Ustekinumab Biosimilar